share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4：持股變動聲明-董事 AFEYAN NOUBAR
美股sec公告 ·  06/15 07:05
牛牛AI助理已提取核心訊息
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on June 12, 2024. The transactions were executed in the open market with prices ranging from $142.97 to $150.24 per share, resulting in a total market value of $2,208,071.31. Following the sales, Afeyan directly holds 2,314,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering total 4,632,149 shares, with the largest portion, 3,880,328 shares, held by Flagship Ventures Fund IV, L.P.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on June 12, 2024. The transactions were executed in the open market with prices ranging from $142.97 to $150.24 per share, resulting in a total market value of $2,208,071.31. Following the sales, Afeyan directly holds 2,314,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering total 4,632,149 shares, with the largest portion, 3,880,328 shares, held by Flagship Ventures Fund IV, L.P.
與 moderna 公司相關的 Noubar Afeyan [MRNA] 於2024年6月12日出售了15000股普通股。這些交易是在市場上以每股142.97美元至150.24美元的價格範圍內進行的，導致總市值達到2,208,071.31美元。在銷售之後，Afeyan 直接持有2,314,015股現代股份。此外，通過與 Flagship Pioneering 相關的各種實體的間接持股總共達到4,632,149股，其中最大的部分，即3,880,328股，由 Flagship Ventures 基金 IV，L.P。持有。
與 moderna 公司相關的 Noubar Afeyan [MRNA] 於2024年6月12日出售了15000股普通股。這些交易是在市場上以每股142.97美元至150.24美元的價格範圍內進行的，導致總市值達到2,208,071.31美元。在銷售之後，Afeyan 直接持有2,314,015股現代股份。此外，通過與 Flagship Pioneering 相關的各種實體的間接持股總共達到4,632,149股，其中最大的部分，即3,880,328股，由 Flagship Ventures 基金 IV，L.P。持有。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。